Fundz

NOWDiagnostics Appoints Jody Douglas Berry as Chief Scientific Officer

PRIVATEMar 14, 2024

Position

Chief Scientific Officer

Company

NOWDiagnostics, Inc.

Jody Douglas Berry
jody.berry@nowdx.com
SpringdaleManufacturingBiotechnologyHealthcareHealth CareMedical Device

Description

NOWDiagnostics (NOWDx) announces the appointment of Jody Douglas Berry, Ph.D. as Chief Scientific Officer (CSO). Dr

Who to call at NOWDiagnostics, Inc., and when

A new leader at NOWDiagnostics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day NOWDiagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NOWDiagnostics, Inc., from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NOWDiagnostics, Inc.

Location

1200 Stewart Pl

Springdale, Arkansas, United States

About

NOWDiagnostics (NOWDx) develops and manufactures 'Touch to Test' over-the-counter and point of care diagnostic tests that yield results in minutes. It is committed to changing healthcare by providing accessible, affordable, and accurate testing for all.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NOWDiagnostics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jody
Likely contact at this company
••••••••@••••••••

See Jody's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NOWDiagnostics, Inc.'s next move

Learn about Strategic plan

NOWDiagnostics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.